Health
Synthetic Mini-Antibody Identified to Combat COVID-19 – SciTechDaily
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to…
SARS-CoV-2’s ability to infect cells relies on interactions between the viral spike protein (magenta) and the protein ACE2 (blue), which is present on the surface of human cells. These interactions can be disrupted by sybodies (black) — synthetic mini-antibodies similar to those produced by camels and llamas. Credit: Rayne Zaayman-Gallant/EMBL
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus…
-
Noosa News19 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News12 hours agoUnlawful wounding charges, Caloundra – Sunshine Coast
-
Noosa News23 hours agoNASAA Certified Organic collapse threatens export capabilities for hundreds of Australian producers
-
Noosa News22 hours agoSugarcane fields reveal devastating long-term impact of north Queensland floods